SCHEMBL311485

SCHEMBL311485

C#CCCCN1CCN(C(=O)NCC)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.58
MAPK1 P28482 2/20 0.50
FAAH O00519 2/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
TSHR P16473 1/20 0.50
ALOX12 P18054 1/20 0.50
MTOR P42345 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 1/20 0.49
BLM P54132 1/20 0.49
PMP22 Q01453 1/20 0.49
HTT P42858 1/20 0.46
HRH2 P25021 1/20 0.46
HRH1 P35367 1/20 0.46
DRD2 P14416 2/20 0.40
DRD3 P35462 2/20 0.40
KDM4E B2RXH2 2/20 0.38
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312907 0.84 POLB (0.52) KMT2AMAPK1FAAHCYP3A4CYP2D6
SCHEMBL11199272 0.80 KMT2A (0.63) KMT2AMAPK1FAAHCYP3A4CYP2D6
SCHEMBL24333807 0.79 KMT2A (0.73) KMT2AMAPK1FAAHCYP3A4CYP2D6
SCHEMBL313821 0.74 POLB (0.55) KMT2AFAAHHTTDRD2DRD3
SCHEMBL4534033 0.73 KMT2A (0.83) KMT2AMAPK1FAAHCYP3A4CYP2D6
SCHEMBL312772 0.73 KDM1A (0.37) MAPK1RAB9AKDM4E
SCHEMBL7316574 0.72 MAOB (0.44) SMN1; SMN2
SCHEMBL311930 0.70 PAOX (0.42) RAB9ADRD3
Hydrochloric Acid SCHEMBL10415232 0.70 FAAH (0.63) KMT2AMAPK1FAAHCYP3A4CYP2D6
SCHEMBL9809310 0.70 HRH1 (0.69) KMT2AMAPK1FAAHCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093229-B2 Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors CONFORMA THERAPEUTICS CORPORATION (US) 2012-01-10 US disclosed
US-20090318387-A1 ALKYNYL PYRROLO[2,3-d]PYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION 2009-12-24 US disclosed
US-7544672-B2 Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors CONFORMA THERAPEUTICS CORPORATION (US) 2009-06-09 US disclosed
EP-1869027-A2 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS Conforma Therapeutics Corporation (US) 2007-12-26 EP disclosed
US-20060223797-A1 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION 2006-10-05 US disclosed
WO-2006105372-A2 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION (US) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318387-A1 ALKYNYL PYRROLO[2,3-d]PYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS HSP90AB2P, HSP90AB1, HSP90AA1 KMT2A 4303/4885MAPK1 1631/4885FAAH 2655/4885
US-20060223797-A1 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS HSP90AB2P, HSP90AB1, HSP90AA1 KMT2A 4204/4885MAPK1 1174/4885FAAH 3002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.